Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

First trimester of pregnancy: ACE inhibitors linked to increased risk of birth defects

Risk for skin lesions increases with low-dose exposure to arsenic in drinking water

Pregnancy: newer antidepressants linked to persistent pulmonary hypertension in newborns

Galantamine appears to protect against nerve agents

Regular use of COX-2 inhibitors associated with increased risk for non-Hodgkin lymphoma

Exubera: no evidence available of an additional therapeutic benefit

Vioxx: myocardial infarction can occur within the first two weeks of use

Drug-induced hepatotoxicity: Acetaminophen, Ketek

Corticosteroids associated with poor outcomes, death in the trauma intensive care unit

Methylphenidate patch to treat attention deficit hyperactivity disorder in children, approved

Prograf to prevent rejection of heart transplant, approved

Relenza for the prevention of influenza A and B in adults and children

Head and neck cancer: treatment with Erbitux extends survival

Emsam is the first transdermal patch for depression

Emsam is the first transdermal patch for depression

Vivitrol for treatment of alcohol-dependent patients, approved

Macugen: rare cases of anaphylaxis/anaphylactoid reactions

Sepsis associated with Mifeprex for medical abortion

Tequin associated with hypoglycemia and hyperglycemia

Hepatotoxity linked to Tracleer

Mobic linked to higher risk of adverse cardiovascular events than Celebrex and Vioxx

Paroxetine: increased risk of suicidal behavior in young adults

FDA has approved Chantix for smoking cessation

Azilect, a new treatment for Parkinson's Disease

Evista associated with increased risk of stroke mortality in postmenopausal women at increased risk for cardiovascular disease

Acetylsalicylic Acid reduces cardiovascular risks in men and women, but differently

Antibiotic Ketek linked to two cases of liver failure and implicated in a third case of hepatitis

Effectiveness of Fentanyl lozenges for breakthrough cancer pain

Advanced cervical cancer: FDA has approved a combination of Hycamtin and Cisplatin

Seasonal affective disorder: FDA has approved Wellbutrin XL

Next Pages 1 2 3 4 5 [6] 7 8 9 10

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions